iSpeak Blog

Read, Learn, Innovate: Top Blog Posts from June 2020

ISPE
coffee and laptop

Featured in this edition of iSpeak Reading Roundup, are the top blog posts from June 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.


Q&A: User Requirements Specifications Related to Commissioning & Qualification

Q&A: User Requirements Specifications Related to Commissioning & Qualification

The User Requirements Specification document contains requirements from multidisciplinary sources and supports design, commissioning and qualification activities, operations, and maintenance. Brief highlights of answers to FAQs from prior workshops.

Learn More


Q&A: Commissioning and Qualification - Quality Unit and System Risk Assessment

Q&A: Commissioning and Qualification - Quality Unit and System Risk Assessment

The guide describes Good Engineering Practice as a quality system, governed by SOPs that Quality approve; Quality approve the user requirements specifications, System Risk Assessment (SRA) and the Qualification acceptance and release report; Engineering, the suitably trained and experienced experts, are responsible for completing installation and operational verification. But note that the guide also allows the testing that will be used to support qualification to be extracted and put into a separate document that Quality pre-and post-approve as seen in Guide

Learn More


Biosimilars & Gene Therapy Development Open ISPE’s 1st Virtual Conference

Biosimilars & Gene Therapy Development Open ISPE’s 1st Virtual Conference

ISPE’s first virtual conference, the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference, is a new format for delivering education, information, and networking—a fitting first virtual meeting for ISPE given the cutting edge nature of the subject matter of biopharma, cell and gene therapies, and ATMPs. Like these technologies, ISPE and the conference attendees are adapting to new modalities—driven by the impacts of the COVID-19 pandemic—to embrace a new way of meeting and exchanging information.

Learn More


How to Stay Connected with Pharma Professionals Around the World During COVID-19

 

How to Stay Connected with Pharma Professionals Around the World During COVID-19

We have all been given a lot of options lately. Google “things to do in quarantine” and you will have your pick from a slew of categories. With all these workout videos -- where to start? Which book to read? Make the trending Degong coffee or join my friends for an online Zumba class? Which conference platform is the best anyway, and why not try them all?

Learn More


Direct to Patient: The Basics & Quality Considerations

 

Direct to Patient: The Basics & Quality Considerations

Making clinical trials more patient centric is among the many challenges facing the pharmaceutical industry. One method of improving the patient experience is by delivering study medication directly to patient homes, also known as Direct-to-Patient or DtP. However, the implementation of Direct-to-Patient may seem insurmountable in a highly regulated industry where specific regulations or guidance is lacking or vague. Additionally, Direct-to-Patient experiences can be inconsistent by country, trial, or therapeutic area.

Learn More